109 related articles for article (PubMed ID: 19097176)
21. Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore.
Lin CH; Tan EK; Chen ML; Tan LC; Lim HQ; Chen GS; Wu RM
Neurology; 2008 Nov; 71(21):1727-32. PubMed ID: 19015489
[TBL] [Abstract][Full Text] [Related]
22. ATP13A2 Gene Variants in Patients with Parkinson's Disease in Xinjiang.
Wang D; Gao H; Li Y; Jiang S; Yang X
Biomed Res Int; 2020; 2020():6954820. PubMed ID: 33335927
[TBL] [Abstract][Full Text] [Related]
23. The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
Park JS; Blair NF; Sue CM
Mov Disord; 2015 May; 30(6):770-9. PubMed ID: 25900096
[TBL] [Abstract][Full Text] [Related]
24. Parkinson's disease-associated ATP13A2/PARK9 functions as a lysosomal H
Fujii T; Nagamori S; Wiriyasermkul P; Zheng S; Yago A; Shimizu T; Tabuchi Y; Okumura T; Fujii T; Takeshima H; Sakai H
Nat Commun; 2023 Apr; 14(1):2174. PubMed ID: 37080960
[TBL] [Abstract][Full Text] [Related]
25. Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.
Park JS; Sue CM
Curr Protein Pept Sci; 2017; 18(7):725-732. PubMed ID: 26965689
[TBL] [Abstract][Full Text] [Related]
26. PARK16 polymorphisms, interaction with smoking, and sporadic Parkinson's disease in Japan.
Miyake Y; Tanaka K; Fukushima W; Kiyohara C; Sasaki S; Tsuboi Y; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M; Nakamura Y;
J Neurol Sci; 2016 Mar; 362():47-52. PubMed ID: 26944116
[TBL] [Abstract][Full Text] [Related]
27. Calpastatin gene (CAST) is not associated with late onset sporadic Parkinson's disease in the Han Chinese population.
Zhang L; Ding H; Wang DH; Zhang YL; Baskys A; Chan P; Zhong Y; Cai YN
PLoS One; 2013; 8(8):e70935. PubMed ID: 23951044
[TBL] [Abstract][Full Text] [Related]
28. Lack of association between the ATP13A2 A746T variant and Parkinson's disease susceptibility in Han Chinese: a meta-analysis.
Pan LS; Wang Z; Ding D; Zhu XP; Leng HL; Deng XB; Xu YM
Int J Neurosci; 2016; 126(7):593-9. PubMed ID: 26000924
[TBL] [Abstract][Full Text] [Related]
29. α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).
Daniel G; Musso A; Tsika E; Fiser A; Glauser L; Pletnikova O; Schneider BL; Moore DJ
Neurobiol Dis; 2015 Jan; 73():229-43. PubMed ID: 25461191
[TBL] [Abstract][Full Text] [Related]
30. Identification of p.Gln858* in ATP13A2 in two EOPD patients and presentation of their clinical features.
Malakouti-Nejad M; Shahidi GA; Rohani M; Shojaee SM; Hashemi M; Klotzle B; Fan JB; Elahi E
Neurosci Lett; 2014 Aug; 577():106-11. PubMed ID: 24949580
[TBL] [Abstract][Full Text] [Related]
31. Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove.
Dehay B; Martinez-Vicente M; Ramirez A; Perier C; Klein C; Vila M; Bezard E
Autophagy; 2012 Sep; 8(9):1389-91. PubMed ID: 22885599
[TBL] [Abstract][Full Text] [Related]
32. alpha-Synuclein and Parkinson disease susceptibility.
Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
[TBL] [Abstract][Full Text] [Related]
33. Association between the estrogen receptor beta gene and age of onset of Parkinson's disease.
Westberg L; Håkansson A; Melke J; Shahabi HN; Nilsson S; Buervenich S; Carmine A; Ahlberg J; Grundell MB; Schulhof B; Klingborg K; Holmberg B; Sydow O; Olson L; Johnels EB; Eriksson E; Nissbrandt H
Psychoneuroendocrinology; 2004 Sep; 29(8):993-8. PubMed ID: 15219649
[TBL] [Abstract][Full Text] [Related]
34. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
[TBL] [Abstract][Full Text] [Related]
35. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
[TBL] [Abstract][Full Text] [Related]
36. Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.
Kong SM; Chan BK; Park JS; Hill KJ; Aitken JB; Cottle L; Farghaian H; Cole AR; Lay PA; Sue CM; Cooper AA
Hum Mol Genet; 2014 Jun; 23(11):2816-33. PubMed ID: 24603074
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.
Tanaka K; Miyake Y; Fukushima W; Kiyohara C; Sasaki S; Tsuboi Y; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M; Nakamura Y;
Neurosci Lett; 2017 Mar; 643():97-102. PubMed ID: 28216333
[TBL] [Abstract][Full Text] [Related]
38. No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease.
Svetel M; Pekmezovic T; Markovic V; Novaković I; Dobričić V; Djuric G; Stefanova E; Kostić V
Eur Neurol; 2013; 70(5-6):257-62. PubMed ID: 24051673
[TBL] [Abstract][Full Text] [Related]
39. Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians.
Das G; Misra AK; Das SK; Ray K; Ray J
Neurosci Lett; 2009 Aug; 460(1):16-20. PubMed ID: 19450659
[TBL] [Abstract][Full Text] [Related]
40. LINGO1 is not associated with Parkinson's disease in German patients.
Klebe S; Thier S; Lorenz D; Nothnagel M; Schreiber S; Klein C; Hagenah J; Kasten M; Berg D; Srulijes K; Gasser T; Deuschl G; Kuhlenbäumer G
Am J Med Genet B Neuropsychiatr Genet; 2010 Sep; 153B(6):1173-8. PubMed ID: 20468067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
